Certain Nanopores and Products Containing the Same: Institution of Investigation, 18648-18649 [2016-07176]
Download as PDF
18648
Federal Register / Vol. 81, No. 62 / Thursday, March 31, 2016 / Notices
Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 701–TA–462 and
731–TA–1156–1158 (Review) and 731–
TA–1043–1045 (Second Review)
(Polyethylene Retail Carrier Bags from
China, Indonesia, Malaysia, Taiwan,
Thailand, and Vietnam). The
Commission is currently scheduled to
complete and file its determinations and
views of the Commission on April 18,
2016.
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
PLACE:
By order of the Commission.
Issued: March 28, 2016.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2016–07358 Filed 3–29–16; 11:15 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–991]
Authority: The authority for institution of
this investigation is contained in section 337
of the Tariff Act of 1930, as amended, and
in section 210.10 of the Commission’s Rules
of Practice and Procedure, 19 CFR 210.10
(2015).
Certain Nanopores and Products
Containing the Same: Institution of
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
February 23, 2016, under section 337 of
the Tariff Act of 1930, as amended, 19
U.S.C. 1337, on behalf of Illumina, Inc.
of San Diego, California; University of
Washington, of Seattle, Washington; and
UAB Research Foundation of
Birmingham, Alabama. A supplement to
the complaint was filed on March 2,
2016. The complaint, as supplemented,
alleges violations of section 337 based
upon the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain nanopores and
products containing same by reason of
infringement of certain claims of U.S.
Patent No. 8,673,550 (‘‘the ’550 patent’’)
and U.S. Patent No. 9,170,230 (‘‘the ’230
patent’’). The complaint further alleges
that an industry in the United States
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:09 Mar 30, 2016
Jkt 238001
exists as required by subsection (a)(2) of
section 337.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The complaint, as
supplemented, except for any
confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public record
for this investigation may be viewed on
the Commission’s electronic docket
(EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The
Office of Unfair Import Investigations,
U.S. International Trade Commission,
telephone (202) 205–2560.
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
March 24, 2016, Ordered That—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain nanopores and
products containing same by reason of
infringement of one or more of claims
2–4, 7–9, 13–15, 17, 18, 20–22, 24, 26–
28, 31–33, 35, 36, and 38–40 of the ’550
patent and claims 1–31 of the ’230
patent, and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding administrative law judge shall
take evidence or other information and
hear arguments from the parties or other
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
interested persons with respect to the
public interest in this investigation, as
appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
Illumina, Inc., 5200 Illumina Way, San
Diego, CA 92122.
University of Washington, UW
CoMotion, 4311 11th Avenue NE.,
Suite 500, Seattle, WA 98105.
UAB Research Foundation, 701 20th
Street South, Administration Building
770, Birmingham, AL 35233.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Oxford Nanopore Technologies Ltd.,
Edmund Cartwright House, 4 Robert
Robinson Avenue, Oxford Science
Park, Oxford, OX4 4GA, United
Kingdom.
Oxford Nanopore Technologies, Inc. 1
Kendall Square, Bldg 200, Cambridge,
MA 02139.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
E:\FR\FM\31MRN1.SGM
31MRN1
Federal Register / Vol. 81, No. 62 / Thursday, March 31, 2016 / Notices
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: March 25, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–07176 Filed 3–30–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Halo
Pharmaceutical, Inc.
Correction
Notice document 2016–06532,
beginning on page 15567 in the issue of
Wednesday, March 23, 2016, was
inadvertently published and is
withdrawn from that issue.
[FR Doc. C1–2016–06532 Filed 3–30–16; 8:45 am]
BILLING CODE 1505–01–D
NUCLEAR REGULATORY
COMMISSION
[NRC–2016–0061]
In the Matter of All Operating Reactor
Licensees
Nuclear Regulatory
Commission.
ACTION: Request for action; receipt.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is giving notice that
by petition dated February 19, 2016,
Roy Mathew, Sheila Ray, Swagata Som,
Gurcharan Singh Matharu, Tania
Martinez Navedo, Thomas Koshy, and
Kenneth Miller (the petitioners) have
requested that the NRC take action with
regard to all current operating nuclear
power plants. The petitioners’ requests
are included in the SUPPLEMENTARY
INFORMATION section of this document.
ADDRESSES: Please refer to Docket ID
NRC–2016–0061 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:09 Mar 30, 2016
Jkt 238001
for Docket ID NRC–2016–0061. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced in this document
(if that document is available in
ADAMS) is provided the first time that
a document is referenced.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
SUPPLEMENTARY INFORMATION: On
February 19, 2016, the petitioners
requested that the NRC take action with
regard to all current operating nuclear
power plants (ADAMS Accession No.
ML16050A212). The petitioners
requested that the NRC either: (1) Issue
orders which require immediate
corrective actions including
compensatory measures to address the
operability of electric power systems in
accordance with their plant Technical
Specifications, and to implement plant
modifications in accordance with
current NRC regulatory requirements
and staff guidance provided in the
references within the 2.206 petition, or
(2) issue orders to immediately
shutdown the nuclear power plants that
are operating without addressing the
significant design deficiency identified
in NRC Bulletin 2012–01, ‘‘Design
Vulnerability in Electric Power
System,’’ since the licensees are not in
compliance with their Technical
Specifications 3.8.1 (typical)
requirements related to onsite and
offsite power systems.
As the basis for this request, the
petitioners refer to a Byron Station
operating event, which led to the NRC’s
issuance of Information Notice 2012–03,
‘‘Design Vulnerability in Electric Power
System,’’ dated March 1, 2012 (ADAMS
Accession No. ML120480170). On July
27, 2012, the NRC issued Bulletin 2012–
01, ‘‘Design Vulnerability in Electric
Power System’’ (ADAMS Accession No.
ML12074A115), to require that the
addressees comprehensively verify their
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
18649
compliance with the regulatory
requirements of General Design Criteria
(GDC) 17, ‘‘Electric Power System,’’ in
Appendix A, ‘‘General Design Criteria
for Nuclear Power Plants,’’ to 10 CFR
part 50 or the applicable principal
design criteria in the updated final
safety analysis report; and the design
criteria for protection systems under 10
CFR 50.55a(h)(2) and 10 CFR
50.55a(h)(3). All licensees provided a
response to Bulletin 2012–01. The NRC
staff conducted an analysis of these
responses, and documented the details
of its review in a summary report dated
February 26, 2013 (ADAMS Accession
No. ML13052A711). Based on the
analysis, the NRC staff determined that
some licensees may not fully comply
with their site-specific license. The
licensees began implementing
compensatory measures and corrective
actions that the NRC staff has been
monitoring.
The request is being treated pursuant
to § 2.206 of title 10 of the Code of
Federal Regulations (10 CFR) of the
Commission’s regulations. The request
has been referred to the Director of the
Office of Nuclear Reactor Regulation. As
provided by 10 CFR 2.206, appropriate
action will be taken on this petition
within a reasonable time.
Dated at Rockville, Maryland, this 21st day
of March 2016.
For the Nuclear Regulatory Commission.
William M. Dean,
Director, Office of Nuclear Reactor
Regulation.
[FR Doc. 2016–06940 Filed 3–30–16; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 50–275; Docket No. 50–323]
In the Matter of Pacific Gas & Electric
Company (Diablo Canyon Nuclear
Power Plant, Units 1 and 2); Notice of
Appointment of Adjudicatory
Employee
Pursuant to 10 CFR 2.4, notice is
hereby given that Dr. Tianqing Cao,
Senior Seismologist, Office of Nuclear
Material Safety and Safeguards, has
been appointed as a Commission
adjudicatory employee within the
meaning of section 2.4, to advise the
Commission regarding issues relating to
a pending appeal filed by petitioner
Friends of the Earth. Dr. Cao has not
previously performed any investigative
or litigating function in connection with
this proceeding. Until such time as a
final decision is issued in this matter,
interested persons outside the agency
E:\FR\FM\31MRN1.SGM
31MRN1
Agencies
[Federal Register Volume 81, Number 62 (Thursday, March 31, 2016)]
[Notices]
[Pages 18648-18649]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07176]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-991]
Certain Nanopores and Products Containing the Same: Institution
of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on February 23, 2016, under section
337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of
Illumina, Inc. of San Diego, California; University of Washington, of
Seattle, Washington; and UAB Research Foundation of Birmingham,
Alabama. A supplement to the complaint was filed on March 2, 2016. The
complaint, as supplemented, alleges violations of section 337 based
upon the importation into the United States, the sale for importation,
and the sale within the United States after importation of certain
nanopores and products containing same by reason of infringement of
certain claims of U.S. Patent No. 8,673,550 (``the '550 patent'') and
U.S. Patent No. 9,170,230 (``the '230 patent''). The complaint further
alleges that an industry in the United States exists as required by
subsection (a)(2) of section 337.
The complainants request that the Commission institute an
investigation and, after the investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES: The complaint, as supplemented, except for any confidential
information contained therein, is available for inspection during
official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone (202) 205-2000. Hearing impaired
individuals are advised that information on this matter can be obtained
by contacting the Commission's TDD terminal on (202) 205-1810. Persons
with mobility impairments who will need special assistance in gaining
access to the Commission should contact the Office of the Secretary at
(202) 205-2000. General information concerning the Commission may also
be obtained by accessing its internet server at https://www.usitc.gov.
The public record for this investigation may be viewed on the
Commission's electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The Office of Unfair Import
Investigations, U.S. International Trade Commission, telephone (202)
205-2560.
Authority: The authority for institution of this investigation
is contained in section 337 of the Tariff Act of 1930, as amended,
and in section 210.10 of the Commission's Rules of Practice and
Procedure, 19 CFR 210.10 (2015).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on March 24, 2016, Ordered That--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain nanopores
and products containing same by reason of infringement of one or more
of claims 2-4, 7-9, 13-15, 17, 18, 20-22, 24, 26-28, 31-33, 35, 36, and
38-40 of the '550 patent and claims 1-31 of the '230 patent, and
whether an industry in the United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1),
the presiding administrative law judge shall take evidence or other
information and hear arguments from the parties or other interested
persons with respect to the public interest in this investigation, as
appropriate, and provide the Commission with findings of fact and a
recommended determination on this issue, which shall be limited to the
statutory public interest factors set forth in 19 U.S.C. 1337(d)(1),
(f)(1), (g)(1);
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainants are:
Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122.
University of Washington, UW CoMotion, 4311 11th Avenue NE., Suite 500,
Seattle, WA 98105.
UAB Research Foundation, 701 20th Street South, Administration Building
770, Birmingham, AL 35233.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Oxford Nanopore Technologies Ltd., Edmund Cartwright House, 4 Robert
Robinson Avenue, Oxford Science Park, Oxford, OX4 4GA, United Kingdom.
Oxford Nanopore Technologies, Inc. 1 Kendall Square, Bldg 200,
Cambridge, MA 02139.
(c) The Office of Unfair Import Investigations, U.S. International
Trade Commission, 500 E Street SW., Suite 401, Washington, DC 20436;
and
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to
[[Page 18649]]
the respondent, to find the facts to be as alleged in the complaint and
this notice and to enter an initial determination and a final
determination containing such findings, and may result in the issuance
of an exclusion order or a cease and desist order or both directed
against the respondent.
By order of the Commission.
Issued: March 25, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016-07176 Filed 3-30-16; 8:45 am]
BILLING CODE 7020-02-P